methylprednisolone has been researched along with Graft-Versus-Host Disease in 229 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (10.92) | 18.7374 |
| 1990's | 66 (28.82) | 18.2507 |
| 2000's | 71 (31.00) | 29.6817 |
| 2010's | 56 (24.45) | 24.3611 |
| 2020's | 11 (4.80) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, L; Jia, M; Li, F; Li, X; Liu, D; Peng, B; Wang, L; Xu, L | 1 |
| Atsuta, Y; Daimon, T; Doki, N; Eto, T; Fukuda, T; Ichinohe, T; Ikegame, K; Inoue, T; Ishii, S; Kaida, K; Katayama, Y; Kawakita, T; Maruyama, S; Ogawa, H; Takada, S; Uchida, N | 1 |
| Chen, C; Chen, X; Dong, T; Ji, J; Kuang, P; Li, J; Liu, T; Liu, Z; Niu, T; Wu, Q; Zeng, Q; Zhang, C; Zhang, H | 1 |
| Billick, M; Liu, J; Monsour, D; Wang, X | 1 |
| Doki, N; Harada, K; Igarashi, A; Inamoto, K; Kaito, S; Kakihana, K; Kobayashi, T; Konishi, T; Kurosawa, S; Nagata, A; Najima, Y; Ohashi, K; Sakaguchi, M; Sakamaki, H; Takezaki, T; Toya, T; Yamada, Y; Yasuda, S; Yoshioka, K | 1 |
| Hirabayashi, K; Komori, K; Kurata, T; Morita, D; Nakazawa, Y; Okura, E; Saito, S; Sakashita, K; Shigemura, T; Tanaka, M; Yanagisawa, R | 1 |
| Hogan, JJ | 1 |
| Dandoy, CE; Davies, SM; El-Bietar, J; Grimley, MS; Khandelwal, P; Lane, A; Yeh, RF; Yu, L | 1 |
| Guo, QL; Li, N; Lin, DD; Wang, L; Wu, JS; Zhao, XF | 1 |
| Li, Z; Liu, W; Ma, H; Qin, M; Wang, T; Wei, A; Yang, Y; Zhang, L; Zhang, R; Zhao, X | 1 |
| Berger, M; Carraro, F; Fagioli, F; Grassitelli, S; Pessolano, R; Saglio, F; Scolfaro, C; Spadea, M; Vassallo, E | 1 |
| Alousi, AM; Bansal, S; Bruera, E; Fu, JB; Ngo-Huang, A; Williams, J; Wu, J; Yadav, R | 1 |
| McClendon, EE; Suzuki, T; Tanawuttiwat, T | 1 |
| Juvonen, E; Nihtinen, A; Niittyvuopio, R; Ruutu, T; Volin, L | 1 |
| Chalandon, Y; Polchlopek Blasiak, K; Simonetta, F; Vargas, MI | 1 |
| Benyó, G; Csordás, K; Horváth, O; Kállay, K; Kassa, C; Kriván, G; Sinkó, J; Stréhn, A; Vásárhelyi, B; Zakariás, D | 1 |
| Chang, YJ; Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, KY; Mo, XD; Sun, YQ; Tang, FF; Wang, FR; Wang, Y; Xu, LP; Yan, CH; Zhang, XH | 1 |
| Joshi, K; Nasser, K; Starobinska, E | 1 |
| Bérczi, V; Fábián, J; Masszi, T; Reményi, P; Tatai, G; Tóth, A | 1 |
| Fujioka, T; Ikegame, K; Inoue, T; Kaida, K; Kato, R; Nakata, J; Ogawa, H; Okada, M; Soma, T; Tamaki, H; Yoshihara, K; Yoshihara, S | 1 |
| Cho, BS; Cho, SG; Eom, KS; Kim, DW; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, GJ; Park, S; Park, SS; Yoon, JH | 1 |
| D'Ascenzo, G; Feci, L; Fimiani, M; Marotta, G; Murdaca, F; Poggiali, S; Rubegni, P | 1 |
| Dalton, JT; Devine, SM; Edwards, RB; Farag, SS; Grever, MR; Hofmeister, CC; Jansak, BS; Johnston, JS; Lucas, DM; Phelps, MA; Poi, MJ | 1 |
| Bucher, C; Bürgler, D; Fischmann, A; Medinger, M; Passweg, J | 1 |
| Hayashi, Y; Hino, M; Inaba, A; Inoue, A; Koh, H; Nakamae, H; Nakane, T; Nakashima, Y; Nanno, S; Nishimoto, M; Okamura, H; Shimono, T | 1 |
| Bhuller, KS; Heran, MK; Rassekh, SR; Wu, JK | 1 |
| Cusack, C; Doyle, AM; Guy, S; Malat, G; Potluri, A; Ranganna, K; Vega, ML; Xiao, G | 1 |
| Hammerstrom, AE | 1 |
| Dandoy, C; Davies, SM; El-Bietar, J; Jodele, S; Myers, KC | 1 |
| Chen, PM; Chien, SH; Chiou, TJ; Fan, NW; Gau, JP; Hsiao, LT; Hu, MH; Liu, CJ; Liu, CY; Liu, JH; Liu, YC; Tzeng, CH; Yu, YB | 1 |
| Fukano, R; Inagaki, J; Kodama, Y; Noguchi, M; Okamura, J | 1 |
| Abdel-Azim, H; Crooks, GM; Kapoor, N; Khazal, S; Kohn, DB; Mahadeo, KM; Shah, AJ; Zhao, Q | 1 |
| Ikebe, T; Kohno, K; Moroga, Y; Nagamatsu, K; Nashimoto, Y; Ogata, M; Saburi, M; Shirao, K; Takano, K; Takata, H; Yoshida, N | 1 |
| Eto, T; Hidaka, M; Ikeda, T; Imamura, M; Ishikawa, T; Kobayashi, R; Miyamura, K; Mori, M; Murata, M; Muroi, K; Ohashi, K; Okada, M; Ozawa, K; Tanaka, J; Taniguchi, S; Uike, N; Yamaoka, M; Yamashita, T | 1 |
| Daloglu, H; Dincer, Z; Karasu, G; Uygun, V; Yesilipek, MA | 1 |
| Cao, XP; Ding, L; Guo, ZK; Han, DM; Liu, J; Wang, HX; Wang, ZD; Xue, M; Yan, HM; Zheng, XL; Zhu, L | 1 |
| Abud, TB; Amparo, F; Ciolino, JB; Dana, R; Di Zazzo, A; Dohlman, TH; Hamrah, P; Saboo, US | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, KY; Mo, XD; Wang, FR; Wang, JZ; Wang, Y; Xu, LP; Yan, CH; Zhang, XH | 1 |
| Dabaja, BS; Kebriaei, P; Medeiros, LJ; Milgrom, SA; Nieto, Y; Pinnix, CC; Rondon, G; Smith, GL; Wogan, CF | 1 |
| Feistritzer, C; Gerner, RR; Kircher, B; Moschen, AR; Moser, P; Nachbaur, D; Tilg, H | 1 |
| Hashida, R; Hashimoto, N; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sakurai, M; Toyama, T | 1 |
| Ikebe, T; Miyazaki, Y; Ogata, M; Ohtsuka, E; Saburi, Y; Sasaki, H; Shirao, K; Takata, H | 1 |
| Atkinson, A; Grunebaum, E; Kavadas, FD; Roifman, CM; Somech, R | 1 |
| Grunebaum, E; Nahum, A; Reid, B; Roifman, CM | 1 |
| Chiba, T; Ito, M; Nakase, H; Yamamoto, S; Yamashita, K | 1 |
| Filippi, R; Fossi, A; Gotti, G; Luzzi, L; Marchi, B; Pasini, FL; Rottoli, P; Voltolini, L | 1 |
| Alousi, AM; Bolaños-Meade, J; Carter, S; Difronzo, N; Goldstein, SC; Hayes-Lattin, B; Ho, VT; Horowitz, MM; Levine, JE; Logan, BR; Pasquini, M; Weisdorf, DJ; Wingard, JR | 1 |
| Ding, BH; Li, YF; Liu, JM; Xuan, HB; Zhang, LS | 1 |
| Adkins, D; Ratanatharathorn, V; White, B; Yang, H | 1 |
| Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P | 1 |
| Abboud, M; Barker, JN; Hawke, R; Heller, G; Patel, KJ; Rice, RD; Scaradavou, A; Young, JW | 1 |
| Alousi, A; Andersson, B; Champlin, R; Couriel, DR; de Lima, M; Giralt, S; Hosing, C; Ippoliti, C; Khouri, I; Saliba, R; Shpall, EJ | 1 |
| Carreras, E; Fernández de Larrea, C; Fernández-Avilés, F; Guerrero, M; Lozano, M; Marín, P; Martínez, C; Rosiñol, L; Rovira, M; Silva, L | 1 |
| Belanger, AR; Lookstein, RL; Nowakowski, FS; Stangl, PA; Sung, CC; Weintraub, JL | 1 |
| Banihosseini, S; Ferrara, JL; Rabbani-Anari, M; Rahimi Darabad, R; Rohanizadegan, M; Salmasian, H; Shakiba, A | 1 |
| Doyle, J; Dupuis, LL; Finkelstein, Y; Gassas, A; Husain, M; Macartney, C; Schechter, T | 1 |
| Baker, M | 1 |
| Alousi, AM; Bolaños-Meade, J; Ho, V; Levine, JE; Logan, B; Weisdorf, D; Wu, J | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Wang, J; Wang, Y; Xu, LP | 2 |
| Bierbach, U; Fischer, L; Hirsch, W; Kiess, W; Landgraf, M; Meixensberger, J; Siekmeyer, M; Siekmeyer, W | 1 |
| Dimopoulou, MN; Giamaiou, K; Goussetis, E; Graphakos, S; Kafritsa, Y; Karkelis, S; Kitra, V; Kitzoni, M; Kontou, E; Paisiou, A; Panayotou, I; Papassotiriou, I; Peristeri, I; Rapsomaniki, E; Roma, E; Stefanaki, K; Tsirigotis, P; Vessalas, G | 1 |
| Gao, J; Gao, PJ; Huang, L; Leng, XS; Li, GM; Wang, D; Zhu, JY | 1 |
| Curley, C; Durrant, S; Jackson, K; Kennedy, GA; Leach, J; McLean, A; Nakagaki, M | 1 |
| Adorno, G; Alfieri, C; Andreani, M; Daniele, N; De Angelis, G; Del Proposto, G; Gallucci, C; Gaziev, J; Isgrò, A; Lanti, A; Lucarelli, G; Marziali, M; Paciaroni, K; Roveda, A; Saltarelli, F; Simone, MD; Sodani, P; Testi, M | 1 |
| Alousi, AM; Champlin, RE; Couriel, DR; Giralt, S; Okoroji, GJ; Rashid, A; Rondon, G; Saliba, RM | 1 |
| Ansari, M; Bieri, S; Chalandon, Y; Chapuis, B; Helg, C; Huguet, S; Miralbell, R; Ozsahin, H; Passweg, J; Roosnek, E; Trombetti, A | 1 |
| Becker, MW; Bernstein, SH; Bruckner, L; Friedberg, JW; Holland, GA; Ifthikharuddin, JJ; Liesveld, JL; Mathes, EJ; Menchel, HL; Milner, LA; Mullen, CA; Phillips, GL; Sasson, T | 1 |
| Al Jefri, A; Al Jumaah, S; Al Muhsen, S; Al Seraihi, A; Al-Hajjar, S; Ayas, M; El Solh, H; Shoukri, M | 1 |
| Anttila, VJ; Juvonen, E; Nihtinen, A; Ruutu, T; Volin, L | 1 |
| Buchvald, F; Gormsen, M; Heilmann, CJ; Müller, KG; Nielsen, KG; Uhlving, HH | 1 |
| Ding, K; Geng, L; Li, L; Liu, H; Liu, X; Sun, Z; Tong, J; Wang, X; Zhu, W | 1 |
| Fujiki, A; Imamura, T; Inoue, M; Ishida, H; Kawa, K; Kawabata, K; Kondo, O; Tamura, S; Yoshihara, T | 1 |
| Ballen, K; Carpenter, PA; Curtin, PT; Cutler, C; Litzow, MR; Martin, PJ; Nieto, Y; Rizzo, JD; Savani, BN; Schriber, JR; Shaughnessy, PJ; Wall, DA; Wingard, JR | 1 |
| Funada, Y; Itoh, T; Kobayashi, K; Kotani, Y; Nagai, H; Nagano, T; Nakata, K; Nishimura, Y; Sakashita, A; Tomita, N | 1 |
| Davies, SM; Jodele, S; Lawrence, J; Marsh, RA; Myers, KC | 1 |
| Cheng, LL; Jon, HC; Kwok, AK; Lam, DS; Neoh, EL; Wat, NM | 1 |
| Fujioka, T; Hosen, N; Ikegame, K; Kawakami, M; Kim, EH; Murakami, M; Ogawa, H; Oji, Y; Oka, Y; Soma, T; Sugiyama, H; Tamaki, H; Tatekawa, T; Tsuboi, A | 1 |
| Fukiya, E; Kimura, S; Kobayashi, Y; Kuroda, J; Murotani, Y; Ozawa, M; Terao, K; Yoshikawa, T | 1 |
| Behnia, M; Busk, M; Cummings, OW; Knox, KS; Kwo, PY; Smith, LR; Vance, GH; Wilkes, DS | 1 |
| Aker, M; Bloom, AI; Nagler, A; Or, R; Resnick, IB; Sasson, T; Shapira, MY; Slavin, S; Verstanding, A; Zilberman, I | 1 |
| Hanna, M; Mackinnon, S; Ward, KN; White, RP | 1 |
| Fujiwara, T; Kita, J; Kubota, K; Nemoto, T; Rokkaku, K; Shimoda, M; Sunakawa, M; Tagaya, N | 1 |
| Ansell, SM; Dispenzieri, A; Elliott, MA; Gastineau, DA; Gertz, MA; Inwards, DJ; Lacy, MQ; Litzow, M; Micallef, IN; Nichols, WL; Plumhoff, EA; Tefferi, A | 1 |
| Bader, P; Bamberg, M; Einsele, H; Faul, C; Hebart, H; Kanz, L; Liebisch, P; Meisner, C; Plasswilm, L; Schäfer, HJ | 1 |
| Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Fujioka, T; Hosen, N; Ikegame, K; Kawakami, M; Kawase, I; Kim, EH; Konaka, Y; Kunitomi, A; Masuda, T; Mukouchi, C; Murakami, M; Nishida, S; Ogawa, H; Oji, Y; Oka, Y; Sugiyama, H; Taniguchi, Y; Tsuboi, A | 1 |
| Chen, H; Guo, NL; Huang, XJ; Lu, DP; Lu, J; Ren, HY; Xu, LP; Zhang, YC | 1 |
| Bermudez, M; Cañete, A; Castel, V; De la Rubia, J; Fernandez, J; Verdeguer, A | 1 |
| Cetkovská, P; Pizinger, K; Skálová, A | 1 |
| Aker, M; Bloom, AI; Muszkat, M; Or, R; Resnick, IB; Sasson, T; Shapira, MY; Slavin, S; Verstandig, A; Zilberman, I | 1 |
| Allison-Thacker, J; Escolar, ML; Hopwood, JJ; Kim, Y; Krivit, W; Kurtzberg, J; Martin, PL; Poe, M; Rubinstein, P; Staba, SL; Szabolcs, P; Wenger, DA; Wood, S | 1 |
| Cantoni, C; Chiossone, L; Cottalasso, F; Dini, G; Haupt, R; Lanino, E; Mingari, MC; Moretta, L; Moretti, S; Morreale, G; Pistorio, A; Vitale, C | 1 |
| Alam, AR; Baer, MR; Bambach, B; Becker, J; Bernstein, ZP; Czuczman, MS; Ford, L; Hahn, T; Lawrence, D; McCarthy, PL; Silva, J; Slack, JL; Wetzler, M | 1 |
| Bansal, D; Das, A; Dass, R; Gupta, A | 1 |
| Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
| Chen, C; Fang, JP; Huang, K; Huang, SL; Li, Y; Zhou, DH | 1 |
| Akpek, G; Bolaños-Meade, J; Hey, JC; Ioffe, O; Vogelsang, GB | 1 |
| Chayama, K; Endo, C; Hamada, S; Hashii, Y; Inagaki, J; Inoue, M; Kawa, K; Kishimoto, T; Miyamura, T; Nakano, T; Nomura, K; Okamura, T; Park, YD; Saito, I; Sakata, N; Sasabe, M; Sato, E; Sawada, A; Yasui, M; Yumura-Yagi, K | 1 |
| Andersson, B; Champlin, R; Couriel, DR; de Lima, MJ; Donato, M; Escalón, MP; Ghosh, S; Giralt, S; Hicks, K; Hosing, C; Hsu, Y; Ippoliti, C; Khouri, IF; Neumann, J; Saliba, R | 1 |
| Auerbach, AD; Defor, TE; Macmillan, ML; Slungaard, A; Tan, PL; Wagner, JE | 1 |
| Ayash, L; Becker, M; Braun, T; Cooke, KR; Ferrara, JL; Hutchinson, R; Jones, D; Levine, JE; Ratanatharathorn, V; Reddy, P; Reynolds, C; Silver, S; Uberti, JP; Whitfield, J; Yanik, G | 1 |
| Arcese, W; Bacigalupo, A; Bruno, B; Cudillo, L; Dallorso, S; Fagioli, F; Guidi, S; Leotta, S; Locasciulli, A; Milone, G; Mordini, N; Scimè, R; Selleri, C; Sica, S; Uderzo, C; Van Lint, MT | 1 |
| Chim, CS; Ooi, GC | 1 |
| Butler, J; Durrant, S; Hill, GR; Kennedy, GA; Morton, J; Western, R | 1 |
| Au, WY; Hon, C; Lam, MF; Yim, SM | 1 |
| Champlin, R; Couriel, DM; de Lima, M; Giralt, S; Lee, HJ; Massey, P; Neumann, J; Oran, B; Saliba, RM; Shin, K | 1 |
| Bambach, B; Benekli, M; Cooper, M; Hahn, T; McCarthy, PL; Roy, HN; Stewart, C; Wallace, P; Williams, BT | 1 |
| Bierbaum, W; Hamadani, M; Maqbool, F; Selby, G; Tfayli, A | 1 |
| Tang, XF | 1 |
| Chao, TY; Chen, CH; Liu, FC | 1 |
| Akiyama, H; Kamata, N; Kisida, S; Ohashi, K; Ohta, K; Sakai, M; Sakamaki, H; Yamashita, T | 1 |
| Dong, M; Lin, Q; Wang, QM; Wen, JY; Wu, XY | 1 |
| Defor, TE; Majhail, NS; Parks, K; Weisdorf, DJ | 1 |
| Fujioka, T; Hasei, H; Ikegame, K; Inoue, T; Kaida, K; Kawakami, M; Kawase, I; Kim, EH; Masuda, T; Ogawa, H; Taniguchi, Y; Yoshihara, S | 1 |
| Holler, E | 1 |
| Darlavoix, I; Dartois, C; Freyer, G; Girard, P; Hénin, E; Michallet, M; Tranchand, B; Vermot-Desroches, C; You, B | 1 |
| Jurgutis, M; Kriukelyte, I; Priluckiene, J; Trociukas, I | 1 |
| Liu, C; Liu, X; Lu, Y; Wang, B; Wu, Z; Yu, L | 1 |
| Azevedo, AM; Bouzas, LF; Ferreira, JL; Lerner, D; Lobo, AM; Lorenzi, N; Nogueira, MC; Pereira, SC; Renault, IZ; Tabak, DG; Tavares, RC | 1 |
| Fujioka, T; Hasei, H; Iiboshi, Y; Ikegame, K; Inoue, T; Kaida, K; Kawakami, M; Kawase, I; Kim, EH; Ogawa, H; Soma, T; Tamaki, H; Taniguchi, Y; Tazuke, Y; Yoshihara, S | 1 |
| Burkhard, PR; Chalandon, Y; Knipp, S; Passweg, J; Terrettaz, M; Verholen, F | 1 |
| Bardy, P; Horvath, N; Hughes, T; Hui, CH; Lee, H; Lewis, I; Mangos, H; Sia, H; To, LB | 1 |
| Bickley, D; Braun, T; Choi, SW; Ferrara, JL; Hutchinson, RJ; Jones, D; Khaled, Y; Kitko, CL; Krijanovski, O; Levine, JE; Mineishi, S; Paczesny, S; Reddy, P; Yanik, G | 1 |
| Castro, LA; Eigler, J; Land, W | 1 |
| Avanzi, G; Bacigalupo, A; Frassoni, F; Marmont, AM; Podesta', M; van Lint, MT; Veneziano, G; Vitale, V | 1 |
| Anagnostou, AA; Dicke, KA; Jagannath, S; Kanojia, MD; Spitzer, G; Vellekoop, L; Verma, DS; Zander, AR | 1 |
| Boileau, J; Bonny, Y; Cousineau, S; D'Angelo, G; Gyger, M; Lacombe, M; Lavallee, R; Perreault, C; Tawil, E | 1 |
| Filipovich, A; Kersey, J; Neudorf, S; Ramsay, N | 1 |
| Ramsay, NK; Storb, R | 1 |
| Ekblom, M; Häyry, P; Leskinen, R; Renkonen, R; Ruutu, T; Volin, L | 1 |
| Anagnostou, A; Hall, RR; Kanojia, M; Zander, A | 1 |
| Bordigoni, P; Brion, A; Burdach, S; Cahn, JY; Kolb, HJ; Lioure, B; Michel, G; Milpied, N; Tiberghien, P; Widjenes, J | 1 |
| Brugger, S; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Knöbl, P; Kyrle, PA; Linkesch, W; Schneider, B; Schwarzinger, I | 1 |
| Anasetti, C; Aro, RM; Collins, RH; Devine, SM; Fay, JW; Nash, RA; Piñeiro, LA; Przepiorka, D; Storb, RF; Wingard, JR | 1 |
| Barnett, MJ; Chan, KW; Klingemann, HG; Meharchand, JM; Nantel, SH; Nevill, TJ; Phillips, GL; Shepherd, JD; Spinelli, JJ; Sutherland, HJ | 1 |
| Anasetti, C; Appelbaum, FR; Doney, K; Etzioni, R; Furlong, T; Gooley, T; Martin, P; Nash, RA; Slattery, J; Storb, R | 1 |
| Brandt, SA; Edwards, JR; Goodman, S; Greer, JP; Leelasiri, A; Stein, RS; Wolff, SN | 1 |
| Kato, S; Yabe, H | 1 |
| Benaim, E; Billing, R; Brenner, MK; Heslop, HE; Krance, RA; Rochester, RJ; Stricklin, LM | 1 |
| Abu-Elmagd, KM; Demetris, J; Fung, J; Furukawa, H; Nakamura, K; Reyes, J; Todo, S; Tzakis, A; Van Thiel, DH; Wright, H | 1 |
| Baxter-Lowe, LA; Bunin, N; Camitta, B; Casper, J; Garbrecht, F; Hunter, J; Lawton, C; Murray, K; Pietryga, D; Truitt, R | 1 |
| Bowden, R; Longton, G; Pepe, M; Sayer, HG; Storb, R | 1 |
| Donadieu, J; Fischer, A; Herbelin, C; Le Deist, F; Racadot, E; Stephan, JL; Wijdenes, J | 1 |
| Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS | 1 |
| Adeva Andany, M; Alonso, A; Arnal, F; García Falcón, T; Lorenzo, D; Martínez, W; Rodríguez Lozano, I; Yebra, T | 1 |
| Eckhaus, MA; Guzzetta, PC; Mixon, A; Nakajima, K; Sachs, DH; Smith, CV; Spitzer, TR; Sundt, TM; Suzuki, T | 1 |
| Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
| Chapuis, B; Delorme, H; Helg, C; Kurtz, J; Miralbell, R; Nouet, P; Wacker, P; Wyss, M | 1 |
| Fries, BC; Khaira, D; Pepe, MS; Torok-Storb, B | 1 |
| Brenner, MK; Douglass, E; Heslop, HE; Horowitz, MM; Hurwitz, C; Krance, R; Kun, L; Mahmoud, H; Ribeiro, R; Santana, V | 1 |
| Escalada, P; González, E; Gorostidi, M; López-Larrea, C; Peces, R; Urra, JM | 1 |
| Agosti, E; Andolina, M; Bonetti, L; Busca, A; de Manzini, A; Giorgi, R; Lanfranchi, A; Locatelli, F; Miniero, R; Porta, F | 1 |
| Appleton, AL; Eastham, EJ; Green, MA; Malcolm, AJ; Pearson, AD; Sviland, L | 1 |
| Fisher, LD; Longton, G; Mori, M; Pepe, MS; Pettinger, M; Storb, R | 1 |
| Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
| Hardy, MA; Oluwole, SF; Yaron, I; Yaron, R | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Friedmann, N; Hansen, JA; Martin, PJ; McDonald, GB; Nash, RA; Nelson, BJ; Scannon, PJ; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Weisdorf, D | 1 |
| Azuno, Y; Kaku, K; Kamei, S; Kaneko, T; Matsutani, A; Mori, K; Nakai, K; Nishimura, M; Nomiyama, J; Oka, Y; Okafuji, K; Okubo, M; Okuya, S; Takeuchi, Y; Zaitsu, Y | 1 |
| Akan, H; Arslan, O; Beksaç, M; Gürman, G; Ilhan, O; Koç, H; Konuk, N; Ozcan, M; Uysal, A; Yalçín, S | 1 |
| Ahmed, T; Beer, M; Easaw, SJ; Feldman, EJ; Lake, DE; Seiter, K | 1 |
| Matsuda, T; Nakao, S; Shiobara, S; Sugimori, N; Takamatsu, H; Takami, A; Ueda, M | 1 |
| Cernelc, P; Fortuna, M; Mlakar, U; Pretnar, J | 1 |
| Andolina, M; Colovic, M; Jankovic, G; Maximova, N; Parco, S; Rabusin, M | 1 |
| Ali, II; Egan, TM; Lackner, RP; Messenheimer, JA; Olivier, KN; Paradowski, LJ; Robertson, KR; Vaughn, BV | 1 |
| Johnson, FL | 2 |
| Jantunen, E; Koukila-Kähkölä, P; Niskanen, L; Parkkali, T; Ruutu, P; Ruutu, T; Volin, L | 1 |
| Anasetti, C; Appelbaum, FR; Boeckh, M; Chauncey, TR; Deeg, HJ; Doney, K; Flowers, M; Leisenring, W; Lin, D; Martin, P; Nash, R; Schoch, G; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Bertz, H; Finke, J; Mertelsmann, R; Potthoff, K | 1 |
| Yasukawa, M | 1 |
| Abu-Elmagd, K; Bueno, J; Furukawa, H; Green, M; Kocoshis, S; Reyes, J; Schoner, D; Starzl, TE; Todo, S; Tzakis, A; Yunis, E | 1 |
| Madan, B; Schey, SA | 1 |
| Dinndorf, PA; Jubran, RF | 1 |
| Imai, Y; Moizumi, Y; Sakurai, M; Tabayashi, K; Uchida, S | 1 |
| Kato, K; Kojima, S; Matsuyama, T | 1 |
| Alessandrino, P; Arcese, W; Bacigalupo, A; Bosi, A; Dini, G; Falda, M; Giorgiani, G; Iori, AP; Locasciulli, A; Locatelli, F; Majolino, I; Miniero, R; Rotoli, B; Scimé, R; Uderzo, C; Van Lint, MT | 1 |
| Hatsumi, N; Karasawa, M; Kim, K; Matsushima, T; Murakami, H; Naruse, T; Saito, T; Sakuraya, M; Sato, M; Takada, S; Tamura, J | 1 |
| Berger, C; Braumann, D; de Witt, M; Erttmann, R; Fiedler, W; Grimm, J; Horstmann, M; Hossfeld, KD; Illiger, HJ; Kabisch, H; Kröger, N; Krüger, W; Kuse, R; Schönrock, P; Stockshläder, M; Weh, HJ; Zander, AR; Zeller, W | 1 |
| Carreras, E; Marín, P; Martínez, C; Montfort, N; Montserrat, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Archimbaud, E; Belhabri, A; Fière, D; Guyotat, D; Michallet, M; Molina, L; Nicolini, F; Perrin, MC; Sotto, JJ; Tigaud, JD | 1 |
| Balderson, GA; Clouston, AD; Edwards-Smith, C; Gill, D; Griffin, AD; Hogan, PG; Jonsson, JR; Lynch, SV; Powell, EE; Strong, RW | 1 |
| Baratz, M; Bialy-Golan, A; Bril, S; Gat, A; Gazit, E; Konikof, F; Landau, M; Merhav, HJ; Nakache, R | 1 |
| Abboud, C; Constine, L; DiPersio, J; Duerst, R; Liesveld, J; Linder, T; McKenna, B; Packman, C; Rapoport, A; Rowe, J; Silverman, W; Swift, S; Wedow, L; Zwetsch, L | 1 |
| Abhyankar, SA; Bridges, K; Folk, RS; Gee, AP; Hazlett, L; Henslee-Downey, PJ; Lamb, LS; O'Neal, W; Parrish, RS; Vogt, S | 1 |
| Bilbao, G; Cartner, S; Contreras, JL; Eckhoff, DE; Neville, DM; Ricordi, C; Thomas, FT; Thomas, JM | 1 |
| Allen, J; Barth, RF; Gorman, TE; Julius, CJ; Kennedy, MS; Lasky, LC; Ng, A; Prior, TW | 1 |
| Hamazaki, T; Inoue, A; Inoue, M; Kawa, K; Kishimoto, T; Okamura, T; Sakata, N; Sasabe, M; Yagi, K; Yasui, M | 1 |
| Appelbaum, FR; Deeg, HJ; Flowers, ME; Leisenring, W; Martin, PJ; Storb, RF | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Hovi, L; Saarinen-Pihkala, UM; Saxen, H; Vettenranta, K | 1 |
| Hasegawa, Y; Iwata, H; Kodera, Y; Kubo, T; Minami, S; Morishita, Y; Torii, Y; Yamada, Y | 1 |
| Akpek, G; Anders, V; Lee, SM; Vogelsang, GB | 1 |
| Noda, M; Okita, H; Takeuchi, Y; Takimoto, Y; Tsujimoto, T | 1 |
| Anasetti, C; Appelbaum, FR; Benito, AI; Deeg, HJ; Doney, K; Furlong, T; Martin, PJ; Nash, RA; Papayannopoulou, T; Storb, R; Sullivan, KM; Witherspoon, R | 1 |
| Arcese, W; Cerretti, R; De Felice, L; Donato, V; Fenu, S; Guglielmi, C; Iori, A; Laurenti, L; Mengarelli, A; Micozzi, A; Romano, A; Torromeo, C | 1 |
| Baker, KS; Nagarajan, R; Neglia, J; Ramsay, N | 1 |
| Hara, T; Hattori, H; Ishii, S; Matsuzaki, A; Suminoe, A | 1 |
| Ahmadi, MA; Anderlini, P; Esmaeli, B; Kim, RY; Naderi, AA; Rivera, P | 1 |
| Eibl, M; Greinix, HT; Gritsch, B; Hinterberger, W; Kalhs, P; Knöbl, P; Krieger, O; Lechner, K; Linkesch, W; Lutz, D; Nachbaur, D; Niederwieser, D; Rosenmayr, A | 1 |
| Abu-Elmagd, K; Casavilla, A; Fung, JJ; Nakamura, K; Nour, BM; Reyes, J; Selby, R; Todo, S; Tzakis, AG; Wright, H | 1 |
| Coyle, K; Felker, D; Myers, L; Oblon, DJ | 1 |
| Essell, JH; Halvorson, RD; Harman, GS; Johnson, RA; Rubinsak, JR; Snyder, MJ; Thompson, JM | 1 |
| Alsina, AE; Nagashima, I; Schweizer, RT | 1 |
| Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC | 1 |
| Bloom, EJ; Przepiorka, D; Rosenfeld, CS; Schwinghammer, TL; Shadduck, RK; Shapiro, S; Venkataramanan, R | 1 |
| Atkinson, K; Biggs, JC; Concannon, A; Dodds, A; Turner, J | 1 |
| Beschorner, WE; Funkhouser, AW; Graeber, JE; Sanders, M; Tunnessen, WW; Vogelsang, G; Zehnbauer, B | 1 |
| Holdsworth, RF; Pedersen, JS; Prince, M; Szer, J; van der Weyden, MB; Whyte, G | 1 |
| Reich, S; Slavin, S; Weiss, L | 1 |
| Dunphy, FR; Jagannath, S; LeMaistre, CF; Luke, DR; Meneghetti, CM; Spinolo, JA; Spitzer, G; Williams, LA; Yau, JC; Zagars, GK | 1 |
| Hiraoka, A | 1 |
| Colvin, OM; Santos, GW | 1 |
| Chen, KY; Chen, PM; Chuang, MW; Fan, S; Hsieh, RK; Liu, CJ; Liu, JH; Tzeng, CH; Wang, SY; Yung, CH | 1 |
| Cleary, KR; Gholson, CF; LeMaistre, CF; Yau, JC | 1 |
| Flesch, M; Hervé, P | 1 |
| Barnett, MJ; Buskard, NA; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Shore, TB | 1 |
| Chadwick, VS; Goldman, JM; Gordon-Smith, EC; Hodgson, HJ; Lavender, JP; O'Brien, C; Peters, AM; Saverymuttu, SH | 1 |
| Dauriac, C; Fiere, D; Guyotat, D; Vu Van, H | 1 |
| Brochstein, J; Byers, V; Dupont, B; Flomenberg, N; Kernan, NA; Mischak, RP; O'Reilly, RJ; Scannon, PJ | 1 |
| Elonen, E; Ruutu, T; Volin, L | 1 |
| Bright, EC; Donnenberg, AD; Duff, SC; Hess, AD; Noga, SJ; Rowley, SD; Santos, GW; Saral, R | 1 |
| Atkinson, K; Biggs, J; Ryman, W; Weller, P | 1 |
| Fujimori, Y; Hara, H; Ifuku, H; Kai, S; Kanamaru, A; Kohsaki, M; Misawa, M; Ohe, Y; Okamoto, T; Shinohara, Y | 1 |
| Bostrom, B; Brunning, RD; Goldman, A; Hurd, D; Kim, T; Krivit, W; McGlave, P; Nesbit, M; Ramsay, N; Woods, WG | 1 |
| Appelbaum, FR; Buckner, CD; Deeg, HJ; Doney, K; Kennedy, MS; Sanders, J; Stewart, P; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Appelbaum, FR; Deeg, HJ; Doney, K; Kennedy, MS; Loughran, TP; Storb, R; Sullivan, KM; Thomas, ED | 1 |
| Häyry, P; Lalla, M; Pasternack, A; Virolainen, M | 1 |
16 review(s) available for methylprednisolone and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methylprednisolone; Prednisolone; Randomized Controlled Trials as Topic; Transplantation, Homologous | 2010 |
Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options.
Topics: Adolescent; Anti-Inflammatory Agents; Bronchiolitis Obliterans; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Randomized Controlled Trials as Topic; Steroids; Transplantation, Homologous | 2012 |
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
Topics: Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methylprednisolone; Prednisone; Transplantation Conditioning | 2012 |
Chemotherapy improves thymoma-associated graft-versus-host-disease-like erythroderma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Cisplatin; Dermatitis, Exfoliative; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Humans; Male; Methylprednisolone; Middle Aged; Paclitaxel; Skin; Thymoma; Thymus Neoplasms | 2011 |
[Research progress of graft-versus-host disease after liver transplantation].
Topics: Autoantibodies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Liver Transplantation; Methylprednisolone; Receptors, Interleukin-2 | 2006 |
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
Topics: Acute Disease; Adrenal Cortex Hormones; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Risk Assessment; T-Lymphocytes; Tacrolimus | 2007 |
[After care of kidney transplant patients].
Topics: Adrenal Cortex Hormones; Aftercare; Antilymphocyte Serum; Azathioprine; Cyclosporins; Graft Rejection; Graft vs Host Disease; Humans; Hypertension; Immunosuppression Therapy; Kidney Transplantation; Methylprednisolone; Postoperative Complications; Proteinuria | 1983 |
Acute graft-versus-host disease after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Infant; Leukemia; Lymphocytes; Male; Methotrexate; Methylprednisolone; Middle Aged; Patient Isolation; Premedication; Time Factors; Transplantation, Homologous | 1983 |
Prevention and treatment of acute graft-versus-host disease.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporins; Glycine max; Graft Enhancement, Immunologic; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lectins; Lymphocyte Depletion; Methotrexate; Methylprednisolone; Plant Lectins; Ricin; Soybean Proteins; T-Lymphocytes | 1984 |
Bone marrow transplantation for aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclophosphamide; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppression Therapy; Methylprednisolone; T-Lymphocytes; Transfusion Reaction; Whole-Body Irradiation | 1984 |
[Recent progress in treatment and prophylaxis of graft-versus-host disease].
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Methylprednisolone; Transplantation, Homologous | 1995 |
What is the most effective treatment of children with severe aplastic anemia who lack a matched sibling donor?
Topics: Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Fetal Blood; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Interleukin-3; Methylprednisolone; Nuclear Family; Recombinant Fusion Proteins; T-Lymphocytes; Transplantation, Homologous | 1996 |
[Treatment of transfusion-associated graft-versus-host disease].
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Methylprednisolone; Muromonab-CD3; Transfusion Reaction | 1997 |
Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation.
Topics: Bone Marrow; Cladribine; Combined Modality Therapy; Cyclosporine; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant, Newborn; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Remission Induction; Transplantation, Homologous; Vinblastine | 2001 |
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis.
Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Mitoxantrone; Prednisolone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2001 |
Pharmacological purging of bone marrow with reference to autografting.
Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic | 1986 |
49 trial(s) available for methylprednisolone and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial.
Topics: Acute Disease; Adrenal Cortex Hormones; Biomarkers; Clinical Trials, Phase II as Topic; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methylprednisolone; Multicenter Studies as Topic; Nitriles; Prospective Studies; Pyrazoles; Pyrimidines; Randomized Controlled Trials as Topic; Steroids | 2022 |
The MAGIC algorithm probability (MAP)-guided preemptive therapy of acute graft versus host disease with methylprednisolone: A randomized controlled trial.
Topics: Acute Disease; Algorithms; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methylprednisolone; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2023 |
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia.
Topics: Adolescent; Adult; Aged; Allografts; Antilymphocyte Serum; Cyclophosphamide; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Male; Methylprednisolone; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2020 |
A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Transplantation, Homologous; Young Adult | 2018 |
Effects of Low-Dose Glucocorticoid Prophylaxis on Chronic Graft-versus-Host Disease and Graft-versus-Host Disease-Free, Relapse-Free Survival after Haploidentical Transplantation: Long-Term Follow-Up of a Controlled, Randomized Open-Label Trial.
Topics: Adult; Disease-Free Survival; Female; Femur Head Necrosis; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Humans; Infections; Male; Methylprednisolone; Middle Aged; Premedication; Transplantation, Haploidentical; Transplantation, Homologous | 2019 |
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease.
Topics: Adenosine Deaminase Inhibitors; Adult; Antibodies, Monoclonal; Area Under Curve; Blood Transfusion, Autologous; Creatinine; Cyclosporine; Drug Resistance; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infliximab; Lymphocyte Transfusion; Male; Methotrexate; Methylprednisolone; Middle Aged; Pentostatin; Renal Insufficiency; Stem Cell Transplantation; Tacrolimus; Young Adult | 2013 |
Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD.
Topics: Adult; Aged; Feasibility Studies; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intra-Arterial; Intestinal Diseases; Male; Methylprednisolone; Middle Aged; Remission Induction; Treatment Failure; Treatment Outcome; Vascular Access Devices | 2014 |
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Male; Mesenchymal Stem Cell Transplantation; Methylprednisolone; Middle Aged; Prednisolone; Severity of Illness Index; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Conjunctival Diseases; Corneal Diseases; Double-Blind Method; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Prospective Studies; Tacrolimus | 2016 |
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Child; Diphtheria Toxin; Drug Therapy, Combination; Etanercept; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Infections; Interleukin-2; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pentostatin; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Survival Rate; Treatment Outcome | 2009 |
Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methylprednisolone; Multiple Myeloma; Safety; Treatment Outcome | 2009 |
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
Topics: Acute Disease; Adult; Aged; Antibodies, Monoclonal; Bone Marrow Transplantation; Female; Graft vs Host Disease; Humans; Infliximab; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
Graft-versus-host disease treatment: predictors of survival.
Topics: Adrenal Cortex Hormones; Adult; Diphtheria Toxin; Etanercept; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Interleukin-2; Methylprednisolone; Middle Aged; Pentostatin; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Survival Analysis; Treatment Outcome | 2010 |
Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Survival Rate; Treatment Outcome | 2011 |
Higher CD3(+) and CD34(+) cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Antigens, CD34; Bone Marrow Transplantation; Busulfan; CD3 Complex; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Methylprednisolone; Myeloablative Agonists; Siblings; Thalassemia; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Prognostic value of response after upfront therapy for acute GVHD.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Infliximab; Male; Methylprednisolone; Middle Aged; Stem Cell Transplantation; Survival Rate; Transplantation, Homologous | 2012 |
Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; C-Reactive Protein; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Erythema; Female; Fever; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Male; Methylprednisolone; Middle Aged; Neutrophils; Retrospective Studies; Risk Factors; Survival Rate; Syndrome; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2012 |
[Comparison study on treatment of acute graft-versus-host disease with low-dose methotrexate in combination with low-dose methylprednisolone or standard-dose methylprednisolone].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Young Adult | 2011 |
Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial.
Topics: Adolescent; Adult; Child; Drug Resistance; Female; Graft vs Host Disease; Hepatic Artery; Humans; Immunosuppressive Agents; Infusions, Intra-Arterial; Male; Methotrexate; Methylprednisolone; Renal Insufficiency | 2004 |
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Proportional Hazards Models; Sirolimus; Tacrolimus | 2005 |
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Etanercept; Female; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Pilot Projects; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tacrolimus; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2005 |
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antilymphocyte Serum; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Risk Assessment; Survival Analysis | 2006 |
Muromonab-CD3 (Orthoclone OKT3), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; CD3 Complex; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; T-Lymphocytes; Transplantation, Homologous | 2006 |
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Topics: Adult; Antilymphocyte Serum; Bone Marrow; Busulfan; CD4 Lymphocyte Count; Combined Modality Therapy; Cytokines; Disease-Free Survival; Family; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; T-Lymphocytes; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2006 |
Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Karnofsky Performance Status; Male; Methylprednisolone; Middle Aged; Models, Biological | 2007 |
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Living Donors; Methotrexate; Methylprednisolone; Mycophenolic Acid; Myeloablative Agonists; Postoperative Complications; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2008 |
High dose bolus methylprednisolone for the treatment of acute graft versus host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Delayed-Action Preparations; Female; Graft vs Host Disease; Histocompatibility; Humans; Intestines; Liver; Male; Methotrexate; Methylprednisolone; Middle Aged; Skin | 1983 |
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Placebos; Transplantation, Homologous | 1995 |
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Pilot Projects; Tacrolimus; Tissue Donors | 1995 |
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.
Topics: Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft vs Host Disease; Histocompatibility Testing; Humans; Kidney; Male; Methotrexate; Methylprednisolone; Middle Aged; Pilot Projects; Survival Analysis; Tacrolimus; Transplantation, Homologous | 1995 |
Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infections; Male; Methotrexate; Methylprednisolone; Survival Rate | 1995 |
Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention.
Topics: Anemia, Aplastic; Bacteremia; Bacterial Infections; Bone Marrow Transplantation; Candidiasis; Female; Fungemia; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Myelodysplastic Syndromes; Regression Analysis; Risk Factors; Sepsis; Whole-Body Irradiation | 1994 |
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation | 1994 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors.
Topics: Adult; Bone Marrow Transplantation; Child; Female; Graft vs Host Disease; HLA Antigens; Humans; Immunotoxins; Male; Methylprednisolone; Ricin; T-Lymphocytes | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; CD5 Antigens; Child; Child, Preschool; Combined Modality Therapy; Double-Blind Method; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Immunotoxins; Infant; Kidney Diseases; Lymphocyte Depletion; Male; Methylprednisolone; Middle Aged; Ricin; T-Lymphocytes, Cytotoxic; Treatment Outcome | 1996 |
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Respiratory Insufficiency; Transplantation Conditioning; Treatment Outcome | 1997 |
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Infant; Infections; Italy; Male; Methylprednisolone; Middle Aged; Nuclear Family; Prospective Studies; Recurrence; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1998 |
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Time Factors; Transplantation, Homologous | 1997 |
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Survival Rate; Transplantation, Homologous | 1999 |
[Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Methylprednisolone; Premedication; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2000 |
Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Middle Aged; Time Factors | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
Intestinal transplantation in composite visceral grafts or alone.
Topics: Adult; Alprostadil; Child, Preschool; Female; Gastrointestinal Motility; Graft Rejection; Graft vs Host Disease; Humans; Infant; Intestinal Absorption; Intestinal Diseases; Intestine, Small; Intestines; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Parenteral Nutrition; Postoperative Complications; Short Bowel Syndrome; Surgical Wound Infection; Survival Rate; Tacrolimus | 1992 |
Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.
Topics: Actuarial Analysis; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Whole-Body Irradiation | 1992 |
Pharmacological purging of bone marrow with reference to autografting.
Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic | 1986 |
Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Cyclosporins; Female; Graft vs Host Disease; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Diseases; Male; Methylprednisolone; Middle Aged; Pancreatitis; Prospective Studies; Random Allocation; Transplantation, Homologous | 1985 |
Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methylprednisolone; Pulmonary Fibrosis | 1985 |
165 other study(ies) available for methylprednisolone and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
Topics: Animals; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Methylprednisolone; Mice; Retrospective Studies; Unrelated Donors | 2023 |
Central nervous system graft-versus-host disease in a 68-year-old man presenting with myoclonus.
Topics: Aged; Brain Diseases; Central Nervous System Diseases; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Myelodysplastic Syndromes; Myoclonus; Pulse Therapy, Drug; Transplantation, Homologous | 2019 |
Comparative analysis of graft-versus-host disease prophylaxis with tacrolimus in combination with methylprednisolone or methotrexate after umbilical cord blood transplantation.
Topics: Fetal Blood; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Tacrolimus | 2020 |
A Case of Nephrotic Syndrome after Allogeneic Stem Cell Transplantation.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Diuretics; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Nephrotic Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Rituximab; Tacrolimus; Transplantation, Homologous | 2020 |
Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa.
Topics: Abatacept; Adolescent; beta-Thalassemia; Busulfan; Calcineurin Inhibitors; Child; Child, Preschool; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Retrospective Studies; Thiotepa; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2021 |
Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: A report of 11cases.
Topics: Acute Disease; Adult; Aged; Basiliximab; Chimerism; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Survival Analysis; T-Lymphocytes; Treatment Outcome | 2020 |
Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
Topics: Child; Child, Preschool; China; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Doxorubicin; Drug Therapy, Combination; Etoposide; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Prognosis; Remission Induction; Retrospective Studies; Transplantation Conditioning; Treatment Outcome | 2020 |
Successfully treated severe COVID-19 and invasive aspergillosis in early hematopoietic cell transplantation setting.
Topics: Adenosine Monophosphate; Alanine; Amphotericin B; Coinfection; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Male; Methylprednisolone; Myeloablative Agonists; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Transplantation Conditioning; Treatment Outcome; Young Adult | 2021 |
An Exploratory Study on Physical Function in Stem Cell Transplant Patients Undergoing Corticosteroid Treatment for Acute Graft-Versus-Host-Disease.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cohort Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methylprednisolone; Middle Aged; Muscle Strength; Muscle Weakness; Walk Test | 2021 |
Arrhythmia in Bone Marrow Transplant Unit.
Topics: Adult; Atrioventricular Block; Bone Marrow Transplantation; Bradycardia; Electrocardiography; Female; Graft vs Host Disease; Heart Block; Hemorrhage; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Diseases; Lung Diseases; Methicillin-Resistant Staphylococcus aureus; Methylprednisolone; Mycophenolic Acid; Pneumonia, Staphylococcal; Skin Diseases; Tacrolimus; Transplantation, Homologous | 2017 |
Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation.
Topics: Central Nervous System; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Injections, Spinal; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Middle Aged; Treatment Outcome | 2018 |
Antithymocyte Globuline Therapy and Bradycardia in Children.
Topics: Adolescent; Antilymphocyte Serum; Bradycardia; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Methylprednisolone; Retrospective Studies | 2019 |
Pericardial effusion as a complication of chronic graft versus host disease.
Topics: Anemia, Aplastic; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cardiac Tamponade; Echocardiography; Edema; Graft vs Host Disease; Humans; Male; Methylprednisolone; Pericardial Effusion; Pericardiocentesis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2018 |
Effectiveness of intra-arterial steroid administration for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease.
Topics: Acute Disease; Adult; Female; Follow-Up Studies; Gastrointestinal Tract; Glucocorticoids; Graft vs Host Disease; Humans; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antilymphocyte Serum; Cord Blood Stem Cell Transplantation; DNA, Viral; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Interleukin-6; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Roseolovirus Infections; Transplantation Conditioning; Virus Activation; Young Adult | 2019 |
A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.
Topics: Adult; Calcineurin Inhibitors; Central Nervous System; Chronic Disease; Female; Graft vs Host Disease; Humans; Methylprednisolone; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Plasma Exchange; Transplantation, Homologous | 2019 |
Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Topics: Acute Disease; Adult; Allografts; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Photopheresis; Retrospective Studies; Stem Cell Transplantation; Steroids; Transplantation Conditioning | 2013 |
Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluid.
Topics: Antibodies, Protozoan; Biomarkers; Clindamycin; Cord Blood Stem Cell Transplantation; Early Diagnosis; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin M; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Tacrolimus; Toxoplasma; Toxoplasmosis, Cerebral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Intra-arterial methylprednisolone for severe steroid refractory gastrointestinal graft-versus-host disease.
Topics: Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Combined Modality Therapy; Drug Resistance; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Infusions, Intra-Arterial; Leukemia, Myeloid, Acute; Methylprednisolone; Prognosis; Steroids; Thalassemia | 2014 |
Successful treatment of acute severe graft-versus-host-disease in a pancreas-after-kidney transplant recipient: case report.
Topics: Adult; Antibodies, Monoclonal; Basiliximab; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Pancreas Transplantation; Recombinant Fusion Proteins; Tacrolimus | 2014 |
Possible amlodipine-induced hepatotoxicity after stem cell transplant.
Topics: Aged; Alanine Transaminase; Amlodipine; Antihypertensive Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hypertension; Liver Function Tests; Male; Methylprednisolone; Prednisone | 2015 |
Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.
Topics: Adolescent; Anti-Inflammatory Agents; Bilirubin; Child; Child, Preschool; Female; Fibrinolytic Agents; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia; Liver; Male; Methylprednisolone; Multiple Organ Failure; Neuroblastoma; Polydeoxyribonucleotides; Retrospective Studies; Transplantation, Homologous | 2015 |
Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Aspergillosis; Diabetes Mellitus, Type 2; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Risk Factors; Transplantation, Homologous; Treatment Outcome; Young Adult | 2016 |
Mycophenolate mofetil for treatment of steroid-refractory acute graft-versus-host disease after pediatric hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methylprednisolone; Mycophenolic Acid; Prednisone; Retrospective Studies; Treatment Outcome | 2015 |
Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Gene Expression; Genetic Diseases, Inborn; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Myeloablative Agonists; Pilot Projects; Survival Analysis; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine | 2015 |
[Hypofibrinogenemia associated with steroid therapy for the patients who developed GVHD after allogeneic stem cell transplantation].
Topics: Acute Disease; Adult; Afibrinogenemia; Aged; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2015 |
Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study.
Topics: Adolescent; Blood Platelets; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Methylprednisolone; Mycophenolic Acid; Neutrophils; Retrospective Studies; Risk; Sepsis; Tacrolimus; Tissue Donors; Transplantation Conditioning | 2016 |
[Mesenchymal Stem Cells Combined with Budesonide, Almeterol and Azithromycin for the Treatment of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation].
Topics: Azithromycin; Bronchiolitis Obliterans; Budesonide; Combined Modality Therapy; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mesenchymal Stem Cell Transplantation; Methylprednisolone; Salmeterol Xinafoate | 2016 |
Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatments.
Topics: Adolescent; Adult; Bronchoalveolar Lavage Fluid; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Pneumonia; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2016 |
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Biphenotypic, Acute; Male; Methylprednisolone; Pentostatin; Photopheresis; Radiotherapy, Adjuvant; Tacrolimus; Transplantation, Homologous; Young Adult | 2016 |
Treatment With α-1-Antitrypsin for Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease: A Report of 2 Cases.
Topics: Acute Disease; Aged; alpha 1-Antitrypsin; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation | 2016 |
False-positive serum (1, 3)-β-D-glucan elevation due to intake of seaweed in a hematopoietic stem cell transplant recipient.
Topics: Antigens, Fungal; beta-Glucans; False Positive Reactions; Food; Galactose; Glucans; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Kelp; Male; Mannans; Methylprednisolone; Middle Aged; Proteoglycans; Sezary Syndrome; Tomography, X-Ray Computed; Transplantation Conditioning | 2017 |
Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation.
Topics: Adult; Allografts; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Humans; Immunosuppressive Agents; Influenza Vaccines; Infusions, Intravenous; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Prednisolone; Tacrolimus; Treatment Outcome | 2017 |
High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency.
Topics: Acute Disease; Anti-Inflammatory Agents; Bone Marrow Transplantation; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Infant; Infant, Newborn; Male; Methylprednisolone; Retrospective Studies; Severe Combined Immunodeficiency | 2008 |
Matched unrelated bone marrow transplant for Omenn syndrome.
Topics: Anti-Inflammatory Agents; Biomarkers; Bone Marrow Cells; Bone Marrow Transplantation; Chimerism; Female; Graft vs Host Disease; Histocompatibility; Humans; Immunoglobulins; Infant; Living Donors; Lymphocyte Count; Male; Methylprednisolone; Prospective Studies; Severe Combined Immunodeficiency; Treatment Outcome | 2009 |
Clinical challenges and images in GI. Image 4. Transplant-associated thrombotic microangiopathy of the colon accompanied by graft-versus-host disease.
Topics: Adult; Biopsy, Needle; Colonoscopy; Diarrhea; Disease Progression; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunohistochemistry; Male; Methylprednisolone; Multiple Myeloma; Purpura, Thrombotic Thrombocytopenic; Risk Factors; Severity of Illness Index | 2009 |
Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids.
Topics: Acute Disease; Adult; Bronchiectasis; Ciliary Motility Disorders; Dose-Response Relationship, Drug; Glucocorticoids; Graft vs Host Disease; Humans; Infusions, Intravenous; Lung Transplantation; Male; Methylprednisolone; Postoperative Complications | 2009 |
[Influence of methylprednisolone on cell component of donor graft and on H-2 haploidentical hematopoietic stem cell transplantation in mice].
Topics: Animals; Antigens, CD34; Dendritic Cells; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; T-Lymphocyte Subsets | 2009 |
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Idarubicin; Immunosuppressive Agents; Leukemia; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Mucositis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Retrospective Studies; Risk Factors; Semustine; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2009 |
Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Exanthema; Female; Fever of Unknown Origin; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Humans; Kaplan-Meier Estimate; Leukocyte Count; Male; Methylprednisolone; Middle Aged; Neutrophils; Postoperative Complications; Retrospective Studies; Syndrome; Transplantation Conditioning; Treatment Outcome; Young Adult | 2010 |
Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; C-Reactive Protein; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Risk Factors; Transplantation, Autologous; Young Adult | 2010 |
Intra-arterial methylprednisolone infusion in treatment-resistant graft-versus-host disease.
Topics: Acute Disease; Adult; Aged; Drug Resistance; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intra-Arterial; Male; Methylprednisolone; Middle Aged; Survival Rate; Treatment Outcome | 2010 |
Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Methylprednisolone | 2010 |
Graft-versus-host disease following autologous transplantation.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methylprednisolone; Multiple Myeloma; Nurse's Role; Nursing Assessment; Oncology Nursing; Transplantation, Autologous | 2010 |
Coincidence of immune thrombocytopenia, intracranial hemorrhage and graft-versus-host disease in an 11-year-old girl.
Topics: Cerebral Infarction; Child; Combined Modality Therapy; Craniotomy; Embolization, Therapeutic; Female; Glucocorticoids; Graft vs Host Disease; Humans; Immunoglobulin G; Infusions, Intravenous; Intracranial Hemorrhages; Methylprednisolone; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Rho(D) Immune Globulin; Spleen; Tomography, X-Ray Computed | 2010 |
Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
Topics: Acute Disease; Adolescent; Albuminuria; Anemia, Aplastic; Biomarkers; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Diarrhea; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Male; Methylprednisolone; Neoplasms; Peripheral Blood Stem Cell Transplantation; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2011 |
Graft versus host disease after liver transplantation: a case report.
Topics: Anti-Inflammatory Agents; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Tacrolimus | 2010 |
Alemtuzumab as salvage therapy for steroid and ATG/etanercept-refractory acute GVHD.
Topics: Acute Disease; Alemtuzumab; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Antineoplastic Agents; Databases, Factual; Disease-Free Survival; Drug Resistance; Etanercept; Female; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Methylprednisolone; Receptors, Tumor Necrosis Factor; Retrospective Studies; Salvage Therapy; Survival Rate | 2011 |
Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Eye Diseases; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hypothyroidism; Immunosuppression Therapy; Infections; Lymphocyte Depletion; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Neoplasms, Second Primary; Nervous System Diseases; Retrospective Studies; Risk Factors; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2011 |
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease.
Topics: Adult; Child; Drug Resistance; Female; Gastrointestinal Tract; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Injections, Intra-Arterial; Liver; Male; Medical Records; Methylprednisolone; Middle Aged; Remission Induction; Retrospective Studies; Severity of Illness Index | 2011 |
Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.
Topics: Age Factors; Anti-Inflammatory Agents; Antibodies, Viral; Case-Control Studies; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Infant; Male; Methylprednisolone; Phosphoproteins; Retrospective Studies; Risk Factors; Transplantation, Homologous; Treatment Outcome; Viral Matrix Proteins; Virus Activation | 2011 |
Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Female; Glucocorticoids; Graft vs Host Disease; Humans; Incidence; Male; Methylprednisolone; Middle Aged; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Young Adult | 2012 |
[Effective infliximab treatment for a recurrent type of acute intestinal graft-versus-host disease accompanied by steroid-induced depression].
Topics: Acute Disease; Antibodies, Monoclonal; Bone Marrow Transplantation; Depression; Epstein-Barr Virus Infections; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Infliximab; Male; Methylprednisolone; Molecular Targeted Therapy; Pancreatitis; Recurrence; Transplantation, Homologous; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2012 |
High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Fibrinolytic Agents; Glucocorticoids; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infant; Liver; Male; Methylprednisolone; Myeloablative Agonists; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2013 |
Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant.
Topics: Antilymphocyte Serum; Bone Marrow Transplantation; Choroid Diseases; Conjunctival Diseases; Cyclosporine; Female; Fluorescein Angiography; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Multiple Myeloma; Retinal Diseases; Vision Disorders; Visual Acuity | 2002 |
Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Antigens, Viral; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Tacrolimus; Transplantation, Homologous | 2002 |
Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Female; Fractures, Bone; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Intellectual Disability; Male; Methylprednisolone; Mycophenolic Acid; Obesity; Peripheral Blood Stem Cell Transplantation; Prednisolone; Remission Induction; Siblings; T-Lymphocytes; Tacrolimus; Tissue Donors; Transplantation Chimera; Transplantation Conditioning; Vidarabine | 2002 |
Acute graft-versus-host disease of the lung after liver transplantation.
Topics: Acute Disease; Administration, Oral; Aged; Bronchitis; Drug Administration Schedule; Female; Glucocorticoids; Graft vs Host Disease; Humans; Injections, Intravenous; Liver Transplantation; Lung Diseases; Lymphocytes; Male; Methylprednisolone; Prednisone; Treatment Outcome | 2002 |
Intra-arterial catheter directed therapy for severe graft-versus-host disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Catheters, Indwelling; Child; Drug Resistance; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intra-Arterial; Liver Diseases; Male; Methotrexate; Methylprednisolone; Middle Aged; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2002 |
Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient.
Topics: Anti-Inflammatory Agents; Bone Marrow Transplantation; Cerebrospinal Fluid; Graft vs Host Disease; Herpesvirus 7, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Myelitis; Paraparesis, Spastic; Roseolovirus Infections; Transplantation, Homologous; Urinary Bladder, Neurogenic; Virus Activation | 2002 |
Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor.
Topics: Administration, Oral; Adult; Chronic Disease; Dermatitis; Female; Glucocorticoids; Graft vs Host Disease; HLA Antigens; Homozygote; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Living Donors; Male; Methylprednisolone; Middle Aged | 2003 |
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
Topics: ADAM Proteins; ADAMTS13 Protein; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Metalloendopeptidases; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Risk Factors; Tissue Donors; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; von Willebrand Factor | 2003 |
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Chronic Disease; Cyclosporine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin.
Topics: Adult; Antineoplastic Agents; Benzamides; Family; Female; Genes, abl; Graft vs Host Disease; Haplotypes; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Biphenotypic, Acute; Methotrexate; Methylprednisolone; Mycophenolic Acid; Pedigree; Piperazines; Pyrimidines; Tacrolimus; Tissue Donors; Transplantation, Homologous | 2003 |
[Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody].
Topics: Adolescent; Adult; Antibodies, Monoclonal; Child; Drug Tolerance; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methylprednisolone; Middle Aged; Receptors, Interleukin-2 | 2003 |
Allogeneic PBPC transplantation in children.
Topics: Adolescent; Anemia; Antigens, CD34; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Methylprednisolone; Peripheral Blood Stem Cell Transplantation; Stem Cells; Transplantation, Homologous | 1999 |
Epidermolysis bullosa acquisita-like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease.
Topics: Bone Marrow Transplantation; Cyclosporine; Epidermolysis Bullosa Acquisita; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Penicillamine; Scleroderma, Systemic | 2003 |
Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.
Topics: Blood Donors; Child Development; Child, Preschool; Cognition; Disease-Free Survival; Female; Fetal Blood; Follow-Up Studies; Graft vs Host Disease; Growth; Hematopoietic Stem Cell Transplantation; Humans; Iduronidase; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methylprednisolone; Mucopolysaccharidosis I; Neutrophils; Transplantation Conditioning | 2004 |
The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity.
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cytotoxicity Tests, Immunologic; Down-Regulation; Flow Cytometry; Glucocorticoids; Graft vs Host Disease; Humans; Immunophenotyping; Infant; Killer Cells, Natural; Methylprednisolone; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2004 |
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Lymphocyte Depletion; Male; Methylprednisolone; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Risk Factors; T-Lymphocytes; Transfusion Reaction; Transplantation, Homologous | 2004 |
Transfusion associated graft versus host disease.
Topics: Child; Child, Preschool; Fatal Outcome; Female; Graft vs Host Disease; Humans; Infusions, Intravenous; Male; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transfusion Reaction | 2004 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
[Prophylaxis and treatment of chronic graft versus host disease].
Topics: Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Methylprednisolone; Mycophenolic Acid; Tacrolimus | 2005 |
Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung.
Topics: Acute Disease; Anti-Inflammatory Agents; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lung; Lung Diseases; Lymphocytes; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pneumonia; Radiography, Thoracic; Steroids; Tacrolimus; Tomography, X-Ray Computed; Transplantation, Homologous | 2005 |
Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Rejection; Graft vs Host Disease; Hematologic Diseases; Humans; Infant; Japan; Male; Methotrexate; Methylprednisolone; Premedication; Retrospective Studies; Tacrolimus; Tissue Donors | 2005 |
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Survival Rate; T-Lymphocytes; Treatment Outcome; Vidarabine | 2006 |
Bulbar palsy in multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Bulbar Palsy, Progressive; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Nerve Diseases; Cyclosporine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin Light Chains; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pneumonia, Aspiration; Pyrazines; Reflex, Abnormal; Transplantation, Homologous; Vincristine | 2005 |
Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Antilymphocyte Serum; Disease-Free Survival; Drug Resistance; Drug Therapy, Combination; Etanercept; Female; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Receptors, Tumor Necrosis Factor; Recurrence; Retrospective Studies; Salvage Therapy | 2006 |
Thrombotic thrombocytopenic purpura after stem cell transplantation presenting as blurred vision and fundal infiltrates.
Topics: Adult; Fundus Oculi; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methylprednisolone; Plasmapheresis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purpura, Thrombotic Thrombocytopenic; Retinal Hemorrhage; Stem Cell Transplantation; Transplantation, Homologous | 2006 |
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy.
Topics: Acute Disease; Adult; Aged; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Muscular Diseases; Myelodysplastic Syndromes; Retrospective Studies; Steroids | 2006 |
Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease.
Topics: Administration, Oral; Antineoplastic Agents; Diarrhea; Diphtheria Toxin; Drug Resistance; Female; Gastrointestinal Diseases; Glucocorticoids; Graft vs Host Disease; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Interleukin-2; Lymphoma, Follicular; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Recombinant Fusion Proteins; Skin Diseases | 2006 |
Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature.
Topics: Adult; Combined Modality Therapy; Glucocorticoids; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Transfusion; Male; Methylprednisolone; Polymyositis; Pulse Therapy, Drug; Recurrence; Stem Cell Transplantation | 2007 |
Immune-mediated myelopathy following allogeneic stem cell transplantation.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes; Pancytopenia; Spinal Cord Diseases; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous | 2006 |
[Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Topics: Adolescent; Adult; Child; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Graft vs Host Reaction; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Middle Aged; Proportional Hazards Models; Recurrence; Retrospective Studies; Survivors; Transplantation, Homologous | 2006 |
Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Cohort Studies; Cord Blood Stem Cell Transplantation; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Proportional Hazards Models; Prospective Studies; Pulmonary Alveoli; Risk; Risk Factors; Staphylococcal Infections; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2006 |
[Chronic graft-versus-host disease presenting as nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Nephrotic Syndrome; Time Factors; Transplantation, Homologous | 2007 |
Diagnosis and treatment for graft-versus-host disease after liver transplantation: two case reports.
Topics: Graft vs Host Disease; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Treatment Outcome | 2007 |
Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infliximab; Leukemia; Male; Methylprednisolone; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Anti-Inflammatory Agents; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Polyradiculopathy | 2008 |
Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Daclizumab; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Medical Audit; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Transplantation, Homologous; Treatment Failure | 2008 |
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Cytokines; Drug Therapy, Combination; Etanercept; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunoglobulin G; Infant; Leukemia; Lymphoma; Methylprednisolone; Middle Aged; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2008 |
High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Diarrhea; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Liver Diseases; Male; Methylprednisolone; Skin Diseases; Texas | 1984 |
Immunological monitoring of bone marrow transplant recipients. I. Major leucocyte subclasses in the blood.
Topics: Adult; Bone Marrow Transplantation; Concanavalin A; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Lymphocyte Activation; Lymphocytes; Male; Methotrexate; Methylprednisolone; Phytohemagglutinins | 1984 |
Pneumatosis intestinalis associated with graft-versus-host disease of the intestinal tract.
Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Female; Graft vs Host Disease; Humans; Intestinal Diseases; Methylprednisolone; Pneumatosis Cystoides Intestinalis | 1984 |
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemolysis; Humans; Hypertension; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Methotrexate; Methylprednisolone; Middle Aged; Nervous System Diseases; Plasmapheresis; Platelet Count; Retrospective Studies; Syndrome; Transplantation, Homologous; Vascular Diseases | 1995 |
Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation.
Topics: Adolescent; Adult; Antigens, CD; Bone Marrow Transplantation; CD5 Antigens; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunotoxins; Infant; Male; Methylprednisolone; Middle Aged | 1995 |
Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, Differentiation; B-Lymphocytes; Child; Child, Preschool; Drug Resistance; Female; Forecasting; Glycolipids; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin M; Infant; Killer Cells, Natural; Lymphocyte Activation; Male; Membrane Lipids; Methylprednisolone; Remission Induction; T-Lymphocytes; Transplantation Immunology | 1995 |
Monitoring and treatment of intestinal allograft rejection in humans.
Topics: Acute Disease; Adult; Alprostadil; Apoptosis; Child; Chronic Disease; Female; Graft Rejection; Graft vs Host Disease; Humans; Intestine, Small; Male; Methylprednisolone; Monitoring, Physiologic; Tacrolimus; Transplantation, Homologous | 1993 |
Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia.
Topics: Actuarial Analysis; Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Leukemia; Lung Diseases, Interstitial; Male; Methylprednisolone; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Tissue Donors; Treatment Outcome; Whole-Body Irradiation; Wisconsin | 1995 |
Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.
Topics: Acute Disease; Antibodies, Monoclonal; Bone Marrow Transplantation; Child, Preschool; Drug Resistance; Female; Graft vs Host Disease; Humans; Infant; Lymphocyte Depletion; Male; Methylprednisolone; Pilot Projects; Receptors, Interleukin-2; T-Lymphocytes | 1994 |
Transfusion-associated graft-versus-host disease in a renal transplant recipient.
Topics: Erythrocyte Transfusion; Erythrocytes; Graft vs Host Disease; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Skin | 1994 |
Bone marrow transplantation in miniature swine: IV. Development of myeloablative regimens that allow engraftment across major histocompatibility barriers.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Graft Survival; Graft vs Host Disease; Lung Diseases, Interstitial; Major Histocompatibility Complex; Methylprednisolone; Swine; Swine, Miniature | 1993 |
Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graft.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia; Lymphocyte Depletion; Male; Methylprednisolone; Middle Aged; Pneumonia; Pulmonary Fibrosis; Radiation Chimera; Radiotherapy Dosage; Whole-Body Irradiation | 1993 |
Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients.
Topics: Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Dexamethasone; Female; Graft vs Host Disease; Granulocytes; Humans; Hydrocortisone; Immunosuppression Therapy; Leukocyte Count; Lymphopenia; Male; Methylprednisolone; Multivariate Analysis; Prednisone; Retrospective Studies | 1993 |
High-dose methylprednisolone inhibits the OKT3-induced cytokine-related syndrome.
Topics: Dose-Response Relationship, Drug; Drug Interactions; Dyspnea; Graft vs Host Disease; Humans; Hypotension; Immunosuppressive Agents; Methylprednisolone; Muromonab-CD3; Pulmonary Edema; Syndrome | 1993 |
Low incidence of GvHD and rejection after pharmacological ex vivo modulation of bone marrow in 2-3 antigens mismatched BMT.
Topics: Bone Marrow; Bone Marrow Transplantation; Child; Graft Rejection; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Incidence; Methylprednisolone; T-Lymphocytes; Vincristine | 1993 |
The need for endoscopic biopsy in the diagnosis of upper gastrointestinal graft-versus-host disease.
Topics: Biopsy; Bone Marrow Transplantation; Child; Cyclosporine; Duodenum; Endoscopy; Endoscopy, Gastrointestinal; Graft vs Host Disease; Humans; Male; Methylprednisolone; Prospective Studies; Rectum | 1993 |
Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods.
Topics: Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Humans; Methylprednisolone; Postoperative Period; Prevalence; Statistics as Topic | 1993 |
UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
Topics: Apoptosis; Azathioprine; Clonal Anergy; Cyclosporine; Cytotoxicity, Immunologic; DNA Damage; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocytes; Methylprednisolone; T-Lymphocyte Subsets; Ultraviolet Rays | 1996 |
Post-transplantation complications of unrelated bone marrow.
Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Immunosuppression Therapy; Male; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Rate; Transplantation, Homologous | 1996 |
Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Clone Cells; Combined Modality Therapy; Drug Resistance, Neoplasm; Fatal Outcome; Female; Graft vs Host Disease; Graft vs Host Reaction; Humans; Immunosuppressive Agents; Leukocyte Transfusion; Male; Methylprednisolone; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Tissue Donors; Transplantation, Homologous | 1996 |
Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen.
Topics: Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Eosinophilia; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Leukemia; Methylprednisolone; Transplantation Conditioning; Transplantation, Homologous | 1996 |
Graft-versus-host disease. Possible higher risk for African American patients.
Topics: Adult; Black People; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Incidence; Male; Methylprednisolone; Retrospective Studies; Risk Factors; Severity of Illness Index | 1996 |
-Rejection of an allogeneic bone marrow graft following successful treatment of severe graft-versus-host disease (GVHD).
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Female; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methylprednisolone | 1996 |
Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
Topics: Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methylprednisolone; Pericardial Effusion; Pleural Effusion; Transplantation, Homologous | 1996 |
Bone marrow transplantation in chronic GvHD and autoimmune diseases.
Topics: Autoimmune Diseases; Bone Marrow Purging; Bone Marrow Transplantation; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Male; Methylprednisolone; Middle Aged; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 1996 |
Seizures in lung transplant recipients.
Topics: Age Factors; Blood-Brain Barrier; Brain; Comorbidity; Cyclosporine; Cystic Fibrosis; Epilepsies, Partial; Graft Rejection; Graft vs Host Disease; Humans; Hypertension; Lung Transplantation; Magnetic Resonance Imaging; Methylprednisolone; Retrospective Studies; Risk Factors; Seizures; Transplantation, Homologous | 1996 |
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.
Topics: Acute Disease; Adolescent; Adult; Aspergillosis; Bone Marrow Transplantation; Chronic Disease; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Leukemia; Male; Methylprednisolone; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Tissue Donors; Transplantation, Homologous | 1997 |
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Transplantation Conditioning | 1997 |
Graft-versus-host disease after liver and small bowel transplantation in a child.
Topics: Exanthema; Fatal Outcome; Female; Glucocorticoids; Graft vs Host Disease; Humans; IgA Deficiency; IgG Deficiency; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Infant; Intestine, Small; Ischemia; Liver; Liver Cirrhosis; Liver Transplantation; Lymphocytes; Methylprednisolone; Multiple Organ Failure; Peritonitis; Pneumonia, Pneumocystis; Sepsis; Short Bowel Syndrome; Tacrolimus | 1997 |
Reversible cortical blindness and convulsions with cyclosporin A toxicity in a patient undergoing allogeneic peripheral stem cell transplantation.
Topics: Adult; Blindness, Cortical; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Erythroblastic, Acute; Methylprednisolone; Seizures | 1997 |
Successful therapy of refractory graft versus host disease with tacrolimus and Psoralen plus ultraviolet light.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Ficusin; Globulins; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Methylprednisolone; Photosensitizing Agents; Radiotherapy, Adjuvant; Tacrolimus; Ultraviolet Therapy | 1998 |
Transfusion-associated graft-versus-host disease in immunocompetent patient: early diagnosis and therapy.
Topics: Aged; Aortic Aneurysm; Aortic Dissection; Cyclosporine; DNA; Glucocorticoids; Graft vs Host Disease; Guanidines; Humans; Immunocompetence; Immunosuppressive Agents; Male; Methylprednisolone; Microsatellite Repeats; Polymorphism, Genetic; Time Factors; Transfusion Reaction | 1998 |
Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Female; Glucocorticoids; Graft vs Host Disease; Growth; Humans; Infant; Leukemia, Myeloid, Acute; Male; Melphalan; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 1998 |
Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Histiocytosis, Non-Langerhans-Cell; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Methylprednisolone; Transplantation, Homologous | 1998 |
Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
Topics: Adolescent; Adult; Antigens, CD19; Antigens, CD34; B-Lymphocyte Subsets; CD4 Antigens; CD8 Antigens; Cell Separation; Chimera; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Infections; Killer Cells, Natural; Kinetics; Leukapheresis; Leukocyte Common Antigens; Lymphocyte Count; Lymphocyte Depletion; Lymphocyte Subsets; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies; T-Lymphocyte Subsets; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation.
Topics: Adult; Biopsy; Drug Eruptions; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukocytes; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Neutropenia; Skin; Tissue Donors; Transplantation Chimera | 1999 |
Graft versus host disease in a liver transplant patient with hepatitis B and hepatocellular carcinoma.
Topics: Aged; Antilymphocyte Serum; Carcinoma, Hepatocellular; Cyclophosphamide; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Hepatitis B; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Methylprednisolone | 1999 |
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Life Tables; Male; Methotrexate; Methylprednisolone; Middle Aged; Nifedipine; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Wiskott-Aldrich Syndrome | 1999 |
Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease.
Topics: Biomarkers; Bone Marrow Transplantation; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Separation; Chronic Disease; Flow Cytometry; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lymphocyte Depletion; Methylprednisolone; Receptors, Immunologic; Receptors, OX40; Receptors, Tumor Necrosis Factor; Transplantation Conditioning; Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1999 |
Long-term functional islet mass and metabolic function after xenoislet transplantation in primates.
Topics: Animals; CD3 Complex; Chlorocebus aethiops; Cyclosporine; Diabetes Mellitus, Type 1; Diphtheria Toxin; Fasting; Glucose Tolerance Test; Graft vs Host Disease; Immunoglobulin Fragments; Immunosuppressive Agents; Immunotoxins; Islets of Langerhans; Islets of Langerhans Transplantation; Macaca fascicularis; Macaca mulatta; Methylprednisolone; Organ Size; Recombinant Fusion Proteins; Transplantation, Heterologous | 2000 |
Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor.
Topics: Bone Marrow; DNA Fingerprinting; Erythrocyte Transfusion; Fatal Outcome; Graft vs Host Disease; Histocompatibility Testing; Homozygote; Humans; Immunosuppression Therapy; Lymphocytes; Major Histocompatibility Complex; Male; Methylprednisolone; Middle Aged; Pancytopenia; Polymerase Chain Reaction; Skin | 2000 |
Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Catheterization, Central Venous; Cause of Death; Child; Child, Preschool; Chronic Disease; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Infant; Male; Methylprednisolone; Mycoses; Neutropenia; Prednisone; Premedication; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2000 |
Osteonecrosis of the femoral head after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Age Factors; Anemia, Aplastic; Bone Marrow Transplantation; Chi-Square Distribution; Female; Femur Head Necrosis; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Injections, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Logistic Models; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Transplantation, Homologous | 2001 |
A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Disease Progression; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Genetic Diseases, Inborn; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infection Control; Life Tables; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome | 2001 |
[Pneumatosis intestinalis after allogeneic bone marrow transplantation for acute lymphocytic leukemia].
Topics: Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Humans; Male; Methylprednisolone; Middle Aged; Pneumatosis Cystoides Intestinalis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2001 |
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Drug Resistance; Female; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Middle Aged; Pilot Projects; Retreatment; Sirolimus; Treatment Outcome | 2001 |
Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Infant; Leukemia; Life Tables; Male; Methylprednisolone; Middle Aged; Premedication; Retrospective Studies; Risk; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation.
Topics: Acetazolamide; Bone Marrow Transplantation; Brimonidine Tartrate; Choroid Diseases; Drug Therapy, Combination; Graft vs Host Disease; Humans; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pain; Quinoxalines; Scleritis; Transplantation, Homologous | 2002 |
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
Topics: Adult; Age Factors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
High-dose methylprednisolone therapy for acute graft-versus-host disease associated with matched unrelated donor bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid; Male; Methylprednisolone; Tissue Donors | 1992 |
Orthotopic porcine small bowel transplantation using low-dose cyclosporine in triple immunosuppressive therapy.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Graft vs Host Disease; Graft vs Host Reaction; Intestine, Small; Methylprednisolone; Swine; Transplantation, Homologous | 1992 |
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes | 1991 |
Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methylprednisolone; Middle Aged; Risk Factors; Time Factors | 1991 |
An acute pulmonary syndrome possibly representing acute graft-versus-host disease involving the lung interstitium.
Topics: Acute Disease; Adult; Biopsy; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Injections, Intravenous; Leukemia; Lung; Male; Methylprednisolone; Pulmonary Fibrosis; Syndrome; Transplantation, Homologous | 1991 |
Graft versus host disease after blood transfusions in a premature infant.
Topics: Antilymphocyte Serum; Combined Modality Therapy; Female; Graft vs Host Disease; Humans; Infant, Newborn; Infant, Premature, Diseases; Methylprednisolone; Transfusion Reaction | 1991 |
Transfusion associated graft-versus-host disease after cardiac surgery: response to antithymocyte-globulin and corticosteroid therapy.
Topics: Antilymphocyte Serum; Coronary Artery Bypass; Graft vs Host Disease; Humans; Male; Methylprednisolone; Middle Aged; T-Lymphocytes; Transfusion Reaction | 1991 |
Effect of cyclosporine A and methylprednisolone on the graft-versus-leukemia effects across major histocompatibility barriers in mice following allogeneic bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Chimera; Cyclophosphamide; Cyclosporins; Disease Models, Animal; Female; Graft vs Host Disease; Histocompatibility; Immunosuppression Therapy; Leukemia, B-Cell; Lymphoid Tissue; Male; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Recurrence | 1990 |
Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease.
Topics: Adolescent; Adult; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged | 1990 |
[Control of graft-vs-host disease].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Female; Graft vs Host Disease; Guanidines; Humans; Leucine; Leukemia; Male; Methylprednisolone; Ribonucleosides | 1990 |
Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Female; Graft vs Host Disease; Humans; Male; Methylprednisolone; Middle Aged; T-Lymphocytes | 1989 |
Steroid-responsive chronic hepatic graft-versus-host disease without extrahepatic graft-versus-host disease.
Topics: Adult; Bone Marrow Transplantation; Cholestasis, Intrahepatic; Female; Graft vs Host Disease; Humans; Liver; Methylprednisolone | 1989 |
[Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Separation; Centrifugation, Density Gradient; Cyclophosphamide; Graft vs Host Disease; Humans; Lectins; Leukemia; Lymphocyte Depletion; Methylprednisolone; Neoplasms; Neprilysin; Pilot Projects; Plant Lectins; Ricin; Soybean Proteins; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1986 |
Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methylprednisolone; Middle Aged; Transplantation, Homologous | 1988 |
Indium-111-labeled autologous leukocyte scanning in gastrointestinal graft versus host disease (GVHD).
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Indium; Leukocytes; Male; Methylprednisolone; Organometallic Compounds; Oxyquinoline; Radioisotopes; Radionuclide Imaging | 1986 |
[Treatment of acute graft versus host reactions with high doses of corticoids].
Topics: Acute Disease; Adult; Graft vs Host Disease; Humans; Methylprednisolone | 1985 |
Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin.
Topics: Acute Disease; Antibodies, Monoclonal; Antigen-Antibody Reactions; Bone Marrow Transplantation; Child; Drug Resistance; Female; Fluorescent Antibody Technique; Graft vs Host Disease; Humans; Immunotoxins; Leukemia, Myeloid, Acute; Methylprednisolone; Ricin; T-Lymphocytes | 1988 |
Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroids.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporins; Drug Evaluation; Drug Therapy, Combination; Finland; Graft vs Host Disease; Humans; Leukemia; Lymphoma; Methylprednisolone | 1988 |
Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxis.
Topics: Antibody Formation; Bone Marrow Cells; Bone Marrow Transplantation; Cell Separation; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Activation; Methylprednisolone; T-Lymphocytes | 1987 |
PUVA therapy for drug-resistant graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporins; Drug Resistance; Female; Graft vs Host Disease; Humans; Male; Methylprednisolone; Mouth Diseases; PUVA Therapy; Skin Diseases | 1986 |
[Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation--combination protocol of high dose methylprednisolone, prednisolone and methotrexate].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child, Preschool; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Methylprednisolone; Prednisolone; Transplantation, Homologous | 1986 |
Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Child; Child, Preschool; Graft vs Host Disease; Humans; Infant; Leukemia; Leukocyte Count; Methylprednisolone; Neoplasm Staging; Prognosis | 1985 |
Bone marrow transplantation in the treatment of sickle cell anemia.
Topics: Anemia, Sickle Cell; Bone Marrow Transplantation; Child; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methylprednisolone; Parenteral Nutrition, Total | 1985 |
Proliferation of white blood cells in the blood of human renal allograft recipients. Lack of correlation with acute rejection episodes.
Topics: Adult; Autoradiography; Azathioprine; Cell Division; Child; DNA; Erythrocytes; Female; Graft Rejection; Graft vs Host Disease; Humans; Kidney Failure, Chronic; Kidney Transplantation; Leukocyte Count; Leukocytes; Lymphocyte Activation; Male; Methylprednisolone; Middle Aged; Renal Dialysis; Thymidine; Time Factors; Transplantation Immunology; Transplantation, Homologous; Tritium | 1972 |